BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34437764)

  • 1. Altered mitochondrial metabolism in peripheral blood cells from patients with inborn errors of β-oxidation.
    Stenlid R; Olsson D; Cen J; Manell H; Haglind C; Chowdhury AI; Bergsten P; Nordenström A; Halldin M
    Clin Transl Sci; 2022 Jan; 15(1):182-194. PubMed ID: 34437764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
    Tucci S; Herebian D; Sturm M; Seibt A; Spiekerkoetter U
    PLoS One; 2012; 7(9):e45429. PubMed ID: 23024820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency.
    Stenlid R; Manell H; Seth R; Cerenius SY; Chowdhury A; Roa Cortés C; Nyqvist I; Lundqvist T; Halldin M; Bergsten P
    Metabolites; 2023 Jun; 13(7):. PubMed ID: 37512487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era.
    Janeiro P; Jotta R; Ramos R; Florindo C; Ventura FV; Vilarinho L; Tavares de Almeida I; Gaspar A
    Eur J Pediatr; 2019 Mar; 178(3):387-394. PubMed ID: 30617651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
    Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
    Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel ACADVL variants resulting in mitochondrial defects in long-chain acyl-CoA dehydrogenase deficiency.
    Chen T; Tong F; Wu XY; Zhu L; Yi QZ; Zheng J; Yang RL; Zhao ZY; Cang XH; Shu Q; Jiang PP
    J Zhejiang Univ Sci B; 2020 Nov.; 21(11):885-896. PubMed ID: 33150772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heat stress and bezafibrate on mitochondrial beta-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay.
    Li H; Fukuda S; Hasegawa Y; Kobayashi H; Purevsuren J; Mushimoto Y; Yamaguchi S
    Brain Dev; 2010 May; 32(5):362-70. PubMed ID: 19589653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biochemical outcome of patients with very long-chain acyl-CoA dehydrogenase deficiency.
    Rovelli V; Manzoni F; Viau K; Pasquali M; Longo N
    Mol Genet Metab; 2019 May; 127(1):64-73. PubMed ID: 31031081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for substrate fatty acyl chain specificity: crystal structure of human very-long-chain acyl-CoA dehydrogenase.
    McAndrew RP; Wang Y; Mohsen AW; He M; Vockley J; Kim JJ
    J Biol Chem; 2008 Apr; 283(14):9435-43. PubMed ID: 18227065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal diagnosis of mitochondrial fatty acid oxidation defects.
    Nada MA; Vianey-Saban C; Roe CR; Ding JH; Mathieu M; Wappner RS; Bialer MG; McGlynn JA; Mandon G
    Prenat Diagn; 1996 Feb; 16(2):117-24. PubMed ID: 8650121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
    Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
    Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
    Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
    Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency.
    Tenopoulou M; Chen J; Bastin J; Bennett MJ; Ischiropoulos H; Doulias PT
    J Biol Chem; 2015 Apr; 290(16):10486-94. PubMed ID: 25737446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel tandem mass spectrometry method for rapid confirmation of medium- and very long-chain acyl-CoA dehydrogenase deficiency in newborns.
    ter Veld F; Mueller M; Kramer S; Haussmann U; Herebian D; Mayatepek E; Laryea MD; Primassin S; Spiekerkoetter U
    PLoS One; 2009 Jul; 4(7):e6449. PubMed ID: 19649258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.
    Laforêt P; Acquaviva-Bourdain C; Rigal O; Brivet M; Penisson-Besnier I; Chabrol B; Chaigne D; Boespflug-Tanguy O; Laroche C; Bedat-Millet AL; Behin A; Delevaux I; Lombès A; Andresen BS; Eymard B; Vianey-Saban C
    Neuromuscul Disord; 2009 May; 19(5):324-9. PubMed ID: 19327992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
    Diekman EF; Ferdinandusse S; van der Pol L; Waterham HR; Ruiter JP; Ijlst L; Wanders RJ; Houten SM; Wijburg FA; Blank AC; Asselbergs FW; Houtkooper RH; Visser G
    Genet Med; 2015 Dec; 17(12):989-94. PubMed ID: 25834949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-chain fatty acid oxidation during early human development.
    Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
    Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.
    Wood JC; Magera MJ; Rinaldo P; Seashore MR; Strauss AW; Friedman A
    Pediatrics; 2001 Jul; 108(1):E19. PubMed ID: 11433098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of mitochondrial long chain fatty acid oxidation and carnitine defects from a single center metabolic genetics clinic.
    Ambrose A; Sheehan M; Bahl S; Athey T; Ghai-Jain S; Chan A; Mercimek-Andrews S
    Orphanet J Rare Dis; 2022 Sep; 17(1):360. PubMed ID: 36109795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice.
    Tucci S; Flögel U; Hermann S; Sturm M; Schäfers M; Spiekerkoetter U
    Biochim Biophys Acta; 2014 May; 1842(5):677-85. PubMed ID: 24530811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.